11ÔÂ28ÈÕ£¬¹ú¶ÈÒ½ÁƱ£ÏÕ¾Ö¡¢ÈËÁ¦×ÊÔ´ºÍÉç»á±£ÏÕ²¿Õýʽ°ä²¼ÁË¡¶¹ú¶È¸ù»ùÒ½ÁƱ£ÏÕ¡¢¹¤É˱£ÏÕºÍÉúÓý±£ÏÕҩƷĿ¼(2024Äê)¡·¡£Êæ¿ì´ï®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ¾­½»Éæ³õ´Î±»ÄÉÈë¹ú¶ÈÒ½±£Ä¿Â¼¡£Ð°æĿ¼½«ÓÚ2025Äê1ÔÂ1ÈÕÕýʽִÐС£

Êæ¿ì´ï^®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ

       ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒÊô±´ÌØÀàѪ֬µ÷½ÚÒ©£¬Í¨¹ýÒÖÔ켫µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥µÄÌìÉú²¢Í¬Ê±Ê¹Æä·Ö»¯´úлÔö¶à£¬½µµÍѪµÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥£»»¹Ê¹ÔØÖ¬µ°°×A1ºÍA11ÌìÉúÔö³¤£¬´Ó¶øÔö¸ß¸ßÃܶÈÖ¬µ°°×µ¨¹Ì´¼¡£Êæ¿ì´ï®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒÓÅ»¯µ¨¼îÑνṹ£¬ÓµÓнϺõÄË®ÈÜÐÔ£¬ÏÔÖøÌáÉýÁËÉúÎïÀûÓöÈ^[1]£»Ò»´ÎÒ»Á££¨135mg£©,Ò»ÌìÒ»´Î£¬ÎÞÐèÓë²Íͬ·þ£¬ÌáÉýÓÃÒ©·½±ãÐÔ^[2]¡£¿ÉÖ±½ÓÔÚÌåÄÚ²ûÑï×÷Óã¬ÎÞÐè¾­¹ý¸ÎÔàÊ×¹ý´úл£¬´Ó¶ø¿É½µµÍ¸ÎÔàÖ°ÊØ^[1]¡£ËµÃ÷ÊéÖ¸³ö£¬±¾Æ·ÓëËûÍ¡ÀàÒ©Îï½áºÏʹÓÃÎÞÐèµ÷Õû±¾Æ·»òºÏÓÃÒ©ÎïµÄ¼ÁÁ¿¡£

ºÏ×÷Õ÷ѯÈÈÏß:4001833668

¿ÉɨÂëµÇ¼ÇºÏ×÷ÐÅÏ¢

²Î¿¼×ÊÁÏ£º

[1]     Elisavet Moutzouri ,Anastazia Kei,Moses S elisaf ,Haralampos J Milionis.Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.Vascular Health and Risk Management 2010:6 525–539.

[2]   ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ˵Ã÷Êé.